1h Free Analyst Time
RUA Life Sciences Plc (RUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
RUA Life Sciences Plc (RUA Life Sciences), formerly AorTech International Plc is a medical device company that focus on exploitation of the world's long-term implantable biostable polymers and technologies used in development of medical devices. The company through its subsidiaries develops and manufactures medical devices, large bore vascular grafts, cardiovascular and soft tissue patches, and tri leaflet polymeric heart valves. It offers Elast-Eon biostable polyurethanes used in medical devices for long term implantation; ECSil, biomedical polymers used in spinal discs, cardiac pacing leads, orthopaedics ; and Elast-Eon reaction injection molding (RIM) products. The company also offer designing and contract manufacturing services to medical device and biotech companies. RUA Life Sciences is headquartered in Ayrshire, the UK.RUA Life Sciences Plc Key Recent Developments
Jul 11, 2022: RUA Life Sciences : Final results for the year ended 31 March 2022Mar 31, 2022: RUA Life Sciences announces Directorate changes
Dec 16, 2021: RUA Life Sciences: Unaudited interim results
Aug 13, 2021: RUA Life Sciences Notice of Annual General Meeting
Aug 10, 2021: RUA Life Sciences: Directorate change
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Sientra Inc
- Medicor Ltd.
- AdvanSource Biomaterials Corporation
- Dow Silicones Corp